In heart failure with reduced ejection fraction, the interventional landscape has recently expanded. New transcatheter approaches are emerging for both mitral and tricuspid secondary (functional) regurgitation. Transcatheter therapies for mitral and tricuspid valve require a more tailored approach than for the aortic valve, because of more heterogeneous clinical scenarios, anatomic features, and mechanisms of valvular lesions.
Keywords: Advanced heart failure; Heart failure with reduced ejection fraction; MitraClip; Mitral regurgitation; Transcatheter mitral valve repair; Transcatheter tricuspid valve repair; Transcatheter valve replacement; Tricuspid regurgitation.
Copyright © 2021 Elsevier Inc. All rights reserved.